Companies: 10,795·Total market cap: $144.5T
Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

PLRXNASDAQHealthcare● Active
$1.15
+$0.00(+0.00%)
Market Cap$71208230
P/E Ratio
52W High$1.95
52W Low$1.09
Overview

Pliant Therapeutics, Inc. (PLRX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PLRX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.84plrx eps ttm · plrx earnings per shareEarnings history
PE Ratio (TTM)plrx pe ratio ttm · plrx price to earningsPE Ratio deep dive
Revenue (TTM)0.00plrx revenue ttm · plrx annual revenueFull revenue history
Dividend YieldNo Dividenddoes plrx pay dividends · plrx dividend yieldDividend history
Shares Outstanding61.4Mplrx shares outstanding · plrx floatShares outstanding history
Next EarningsAug 6, 2026Est.plrx earnings date · plrx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
pliant therapeutics, inc. revenue · plrx revenue 2025
FY 2025Net Income-$149.3M▲ +28.99% YoY
202320242025
pliant therapeutics, inc. net income · plrx profit 2025
FY 2025EPS$-2.43▲ +29.97% YoY
202320242025
plrx eps · pliant therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$113.2MEPS: $-1.84View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy16 analystsis plrx a buy · plrx analyst rating
Strong Buy
0
Buy
8
Hold
7
Sell
1
Strong Sell
0
12-Month Price Target
$3.00Low
$1.15Current
$3.00Avg Target160.87% upside
$3.00High
plrx price target · plrx 12 month forecast

Total: 16 · Buy rate: 50.0%

The PLRX analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +160.87% upside from the current price of $1.15.

Stock Performance

Full History
1D+0.00%
1W-1.71%
1M-5.74%
3M-12.88%
YTD-5.74%
1Y-28.13%
5Y-96.39%

About Pliant Therapeutics, Inc.

CEOBernard Coulie
IPO DateJun 3, 2020
Employees171
CountryUS

Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related di…

what is pliant therapeutics, inc. · plrx stock overview · pliant therapeutics, inc. company profile · who is pliant therapeutics, inc. ceo · plrx NASDAQ · pliant therapeutics, inc. headquarters · pliant therapeutics, inc. business segments

About Stock Overview & Key Data

Pliant Therapeutics, Inc. (PLRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 3, 2020. As of the latest trading session, PLRX stock price is $1.15, with a market capitalization of $71.2M. The stock has returned -28.13% over the past 12 months and -5.74% year-to-date.

According to 16 Wall Street analysts, the consensus rating for Pliant Therapeutics, Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, Pliant Therapeutics, Inc. reported revenue of — and net income of -$149.3M. For detailed data — including Pliant Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Pliant Therapeutics, Inc. (PLRX) stock price is $1.15. The stock is traded on NASDAQ under the ticker symbol PLRX. The 52-week range is $1.09 – $1.95.

PLRX stock pricePLRX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice